Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-05-04 @ 1:01 PM
Study NCT ID:
NCT05036005
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2021-08-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
Sponsor:
Institut fuer Frauengesundheit
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IFG-08-2019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |